Ginkgo Bioworks Holdings - שווי שוק בספרים DNA

Ginkgo Bioworks Holdings (DNA) is creating a digital environment for engineering living organisms, where the Foundry platform accumulates data, increasing customer switching costs. Serving as the primary valuation tool, this price chart complements the metric data at the 0.36 level. The company is currently transforming its model, replacing cost-intensive laboratories with cloud-based AI services and the sale of licenses for its proprietary developments.

When constructing a long-term portfolio, primary screening requires an analysis of the intrinsic value of assets. Book capitalization measures the total volume of equity, determining the actual collateral for creditors and shareholders. For Ginkgo Bioworks Holdings (DNA), this resource supports the development of sustainable bio-alternatives to petrochemicals and the implementation of safety standards. By analyzing the volatility of book capitalization on GURU.Markets, an investor assesses the company's resilience to market panic. The trend of this metric reveals the gap between fundamental value and speculative price.